Banco Santander SA, Reckitt Benckiser Group Plc And Smith & Nephew plc: 3 Stocks I’d Buy When The Market Crashes

These 3 stocks appear to be excellent long term buys: Banco Santander SA (LON: BNC), Reckitt Benckiser Group Plc (LON: RB) and Smith & Nephew plc (LON: SN)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The recent fall in the FTSE 100 has caused pain, worry and despair for many investors. A portfolio that had previously been relatively stable and increasing in value for a number of years is now back to where it was many months ago and, looking ahead, it appears as though volatility is almost certainly set to be on the agenda for the rest of the calendar year.

As a result, many investors are choosing to either sell their holdings in case things do get worse before they get better, or else wait for an improvement before buying. However, both of those moves may be rather unwise in the long term, since it is through buying when prices are low that future profits are made. And, while the theory sounds easy, in practice no share price is ever low without a degree of uncertainty or worry.

Of course, a sensible idea when the market falls is to buy well-diversified businesses. That’s because they should be able to better weather any economic storm and provide a degree of stability which could prove invaluable when the outlook is bleak.

One such company is Reckitt Benckiser (LSE: RB). Certainly, its exposure to Asia is significant and a major reason behind the company’s share price having risen by 232% in the last ten years is the potential for a growing middle class across emerging markets to purchase its products in higher volumes. And, while this story may not be as compelling as it once was, Reckitt Benckiser’s wide range of products in a very wide range of markets means that it is likely to offer stability, resilience and also growth potential in the long run. In other words, if one region or product category underperforms, it has many others to pick up the slack.

Similarly, Santander (LSE: BNC) remains one of the best diversified banks in the world. It operates across the globe and recently took the decision to maintain its exposure to a variety of regions, with its recent placing providing it with the capital to invest in its divisions in both developed and developing markets. Certainly, a dividend cut caused investor sentiment to weaken but, having fallen by over a third in the last year, shares in Santander still yield a very enticing 3.7%. And, with dividends being covered 2.6 times by profit, it looks to be a relatively safe income play for the long term.

Meanwhile, health care stocks such as Smith & Nephew (LSE: SN) remain hugely appealing – especially when their prices have been hurt by uncertainty regarding China. In fact, Smith & Nephew now trades on a price to earnings growth (PEG) ratio of just 1.4, which indicates that its shares look set to continue the run that has seen them soar by 112% in the last five years.

Looking ahead, Smith & Nephew is likely to benefit from increasing demand for its wound care and orthopaedic reconstruction products – especially in the developed world where an ageing population is presenting significant growth potential for the business. With an excellent track record of growth (earnings have risen in each of the last five years), Smith & Nephew remains an ultra-reliable stock for the long term.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »